Literature DB >> 15550992

Tacrolimus ointment (Protopic) for atopic dermatitis.

J C Pascual1, A B Fleisher.   

Abstract

Tacrolimus ointment (Protopic, Fujisawa) is an effective agent in a class of topical immunomodulators. Its mechanism of action is based on calcineurin inhibition, which results in decreased T-cell activation and inflammatory cytokine release. Tacrolimus ointment is safe and effective for short- and long-term treatment of atopic dermatitis (AD) in pediatric and adult patients. The most common adverse events associated with its use are a transient burning sensation and pruritus at the site of application. Unlike topical corticosteroid agents, tacrolimus ointment does not cause a reduction in collagen synthesis or skin thickness. Because tacrolimus ointment does not cause skin atrophy, it may be safely used for months or years on all skin areas, including the face and intertriginous areas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550992

Source DB:  PubMed          Journal:  Skin Therapy Lett        ISSN: 1201-5989


  5 in total

Review 1.  Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.

Authors:  Dene Simpson; Stuart Noble
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Formulation and Evaluation of Transdermal Gel Containing Tacrolimus-Loaded Spanlastics: In Vitro, Ex Vivo and In Vivo Studies.

Authors:  Randa Mohammed Zaki; Mohamed A Ibrahim; Doaa H Alshora; Amal El Sayeh Abou El Ela
Journal:  Polymers (Basel)       Date:  2022-04-09       Impact factor: 4.967

Review 3.  Management of Atopic Dermatitis: The Role of Tacrolimus.

Authors:  Badar Uddin Umar; Sayeeda Rahman; Siddhartha Dutta; Tariqul Islam; Nadia Nusrat; Kona Chowdhury; Wan Farizatul Shima Binti Wan Ahmad Fakuradzi; Mainul Haque
Journal:  Cureus       Date:  2022-08-18

4.  Childhood vitiligo: treatment paradigms.

Authors:  Amrinder Jit Kanwar; M Sendhil Kumaran
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

Review 5.  Vitiligo in Children: A Review of Conventional Treatments.

Authors:  Serena Gianfaldoni; Uwe Wollina; Georgi Tchernev; Jacopo Lotti; Katlein França; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2018-01-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.